Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung Cancer
Clinical trial NCT00530621 · COMPLETED
Trial details
- NCT number
- NCT00530621
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2008-10-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.